



The implantable loop recorder: A tool that is "here to stay"
Carel C. Cock, MD, PhD
Department of Cardiology, VU University Medical Center, Amsterdam, The Neteherlands. 
Address for correspondence: C.C. de Cock, MD, Department of Cardiology, VU University 
Medical Center, Boelelaan 1117, 1081 HV, Amsterdam, The Neteherlands.  Email: 
CC.dCock@vumc.nl
Introduction
         Syncope  is a  common clinical  disorder  accounting for  3 %  for emergency room 
presentations and 1 % of hospital admissions 1. Moreover it has not always a benign course, with 
mortality rates up to 33 % at 1 year in patients with a structural cardiac disorders 2-5. In addition 
costs for investigation for syncope is substantial and about 25 % of all patients remain 
undiagnosed 6.
         Investigation   of   patients   with   recurrent   unexplained   syncope   may   include 
electrocardiography   and   treadmill   exercise   testing,   neurologic   testing,   tilt   table   testing, 
ambulatory Holter monitoring and electrophysiological testing.
         This review will briefly discuss these current available strategies and focus on the 
usefulness of a recently introduced tool using an implantable loop recorder (ILR) in the 
treatment of patients with a recurrent unexplained syncope.
Clinical history and physical examination
         A careful history taking and clinical examination in addition to electrocardiography is 
essential for patients referred for recurrent syncope. History should focus on postural symptoms, 
palpitations, family history (long QT syndrome, Burgada syndrome, cardiomyopathy) and 
should include the use of medication particularly in the elderly patients 7-    9   . Physical examination 
should focus on (orthostatic) blood pressure, cardiac murmurs and specific cardiac disorders e.g. 
aortic or mitral stenosis.The yield of these initial evaluation however is low with less than 50 % 
of patients having a primary diagnosis made.
Electrocardiography
        Electrocardiography is essential in the work-up of patients with unexplained syncope but 
may reveal a direct cause in only 5 % of patients. Pre-excitation patterns, a long QT- interval, the 
recently reported Burgada syndrome and characteristic features in patients with arrhythmogenic 
right ventricular dysplasia should all be considered 7-    9   .
Echocardiography and exercise testing
            Echocardiography  may  reveal  structural  heart  disease  e.g. Cardiomyopathy  but  the 
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diagnostic yield is low in patients without a cardiovascular history and normal physical 
examination. Although more than half of patients with unexplained syncope presented with an 
abnormal echocardiogram, no additional value could be demonstrated in a large series of patients 
reported by Recchia et al 10. In addition a low diagnostic yield of exercise testing was found.
Tilt table testing
        Recently a large number of studies reported on the use of tilt table testing for patients with 
recurrent syncope 11-    14     resulting in an expert consensus on the use of tilt table testing by the 
American College of Cardiology in 1996 15. An international classification for tilt testing for 
patients with induced neurocardiogenic syncope proposed in 1992 indicated that several 
subtypes (i.e. type 2a and type 2b) are candidates for pacing therapy for recurrent syncope. 
Head-up tilt table testing provides the highest yield from all diagnostic procedures in patients 
with recurrent syncope. However still the majority of patients cannot be detected using this test 1. 
Connolly et al.16 recently studied the value of pacing in patients with neurocardiogenic syncope 
and reported a 85 % reduction of symptoms in patients randomly assigned to DDD pacing with a 
rate drop response algorithm. However Benditt 17 commented in an editorial referring to this 
study stating that "the relationship between observations during tilt table induced faints and the 
pathofysiology of spontaneous syncopal events in the same patients had yet to be studied 
adequately". Nonetheless, tilt testing can provided useful information on these patients and can 
be used to select patients responsive to cardiac pacing.
Electrophysiological studies
        The diagnostic yield of electrophysiological testing is highly dependent on patient selection. 
In patients with structural heart disease the yield is more than 50% whereas in patients without 
structural heart disease and a normal EKG diagnostic yield may be around 10% 5. In addition, in 
patients with an abnormal EKG this type of investigation can reveal ventricular arrhythmias or 
bradycardia in 17% and 19% of patients respectively 2, 18. However, a negative test can not rule 
out an arrhythmic cause and has low predictive value, particularly in patients with non-ischemic 
cardiomyopathies, the long QT syndrome and the Brugada syndrome.
Implantable loop recorders
         Recently, implantable loop recorders have become available to study patients with 
unexplained recurrent syncopal events. This device has a solid state loop memory capable of 
storing electrocardiographic events up to 40 minutes before and 2 minutes after the activation. It 
can be easily placed subcutaneously under local anaesthesia and has a battery life of 15 to 18 
months.
        Krahn and co-workers 19 were among the first to describe a high diagnostic yield of the 
implantable loop recorder (ILR) in 16 patients with recurrent syncope. Extensive investigations 
including electrophysiologic studies, treadmill testing, 48-hours ambulatory monitoring and tilt 
table testing failed to obtain a definite diagnosis in these patients. In 94 % of cases recurrent 
syncope had occurred after implantation of the device revealing a arrhythmogenic cause in 60 %. 
Consequently in 40% of these patients no arrhythmias were detected. In all patients with an 
arrhythmogenic cause, successful therapy was implemented.
        A final analysis was recently presented extending the follow-up to 40 ± 10 months 20. From 
the 24 patients included, 52 % presented with an arrhythmic cause with bradycardia in the vast 
majority of patients. Treatment was directed at the underlying cause in the 18 patients who 
received specific diagnosis. During follow up, syncope did not occur in 16 of the18 treated. In 3 
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patients who underwent explantatition of the device after battery end-of-life without recurrent 
syncope, no recurrence was seen . The same group also presented a large series of 85 patients 
with recurrent undiagnosed syncope despite extensive evaluation 21. Patients were eligible if they 
had at least to syncopal episodes within the previous 2 months or if they had a single syncope 
with a history of presyncope. In all ILR was implanted which resulted in detection of rhythms in 
21 patients, the vast majority (18 pts) having a bradycardia. Of interest, in 29 patients no 
arrhythmia was detecteted despite symptoms. In addition, the inability to freeze the device 
occurred in 8 patients. Patients with syncope were more likely to record a arrhythmia during 
symptoms compared to patients with a history of presyncope (70 % vs 24 % p = 0.005). 
         A rather high proportion of patients (32 %) had no symptoms despite prolonged 
monitoring. This spontaneous resolution was also reported by others 20 who noted a 57 % - 80 % 
resolution of symptoms. Van Nierop et al 22 has recently reported on 35 patients who underwent 
implantation of an ILR because of recurrent syncope or presyncopal events. In 83 % of patients a 
symptom-rhythm correlation could be studied, revealing a clear arrhythmia in 23 %, half of them 
having bradycardia. Resolution of symptoms was presented in 70 % whereas the mean annual 
syncopal event rate was significantly decreased after implantation of the loop recorder (4.7 ± 2.4 
vs 1.3 ± 0.7, p < 0.01). These patients were significantly younger and most of them were 
women. In 11 % patients were not capable of activating the device to save the event. This 
relatively large proportion of patients not capable of a proper activation of the loop recorder has 
led to the introduction of a second generation loop recorders capable of storing events after 
detection of a (programmable) heart rate. Although this may seem advantageous it might also 
introduce confounding factors since rhythms may be detected which are completely without 
symptoms. The predicted value of these rhythms have not been studied and should be interpreted 
with great caution 23.
        Interpretation of the stored arrhythmia may also be difficult and is highly depended of the 
quality registration of QRS amplitude and P-wave morphology. Zellerhof and co-workers 24 
compared the stored ECG in 4 different positions in 56 consecutive patients. The best ECG 
quality (defined as the highest QRS amplitude and the best visible P wave, QRS duration and 
QT interval) was found in the left or right sternal position with a horizontal position of the ILR.
Limitations of the device
         With increasing healthcare costs, a proper selection of patients for implantation of an 
implantable loop recorder is mandatory. Total costs of the investigation of patients with 
recurrent syncope is high 6 because of extensive diagnostic testing. Krahn et al 25 demonstrated 
that ILR implantation could reduce costs in a pilot study of 24 patients referred for recurrent 
syncope.
        Although symptom-rhythm correlation can be obtained in the vast majority of patients, 
about 25 % of all patients remain without definite diagnosis despite the use of ILR. In addition a 
relatively large proportion of patients failed to freeze the device ranging from 11 % to 36 % of 
all studies which underscores the need for proper patient selection  21,  22. Previous studies 
demonstrated that patient selection should focus on those subsets with frank syncope which have 
a significantly higher diagnostic yield as compared to patients presenting with pre-syncope.
        With the increasing use of the device other negative aspects have been demonstrated. De 
Cock   and   co-workers  26  investigated   the   potential   interference   from   electronic   article 
surveillance devices and found that interference may occur causing malfunction of this device. 
Cellular phones did not produce any interference. Finally the device is not able to monitor blood 
pressure, which can play a key role in the assessment of vasovagal syncope. It has been 
hypothesized that in the near future these devices will be capable of recording, apart from the 
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arrhythmia, other physiological parameters (such as blood gas analysis) which may further 
increase the diagnostic yield 27, 28.
In conclusion, the implantable loop recorder has been demonstrated to be a very useful tool in 
the work-up of patients with unexplained recurrent syncope "that is here to stay". Undoubtedly 
future development of the device will help us in the treatment of these patients.
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